Bin Li

7PUBLICATIONS
2CO-AUTHORS
Molecular targetsCancer cell biologyCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 08, 2026
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.

|Feb 04, 2026
Caveolin-1 drives immunosuppression in esophageal squamous cell carcinoma by enhancing exosome secretion and macrophage M2 polarization via inhibition of MVB autophagic degradation.

Ke-Rong Zhai, Pei-Lin Zhao, Zi-Han Wang

|Jan 21, 2026
Exploring the genetic link between type 2 diabetes and its complications and esophageal malignancy: A Mendelian randomization study.

Mingzhi Lin, Chongrui Li, Bin Li

|Jul 21, 2025
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in patients with resectable esophageal squamous cell carcinoma: a systematic review and meta-analysis.

Chong-Rui Li, Ming-Zhi Lin, Bin Li

|Jul 17, 2025
Neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study with 2-year survival analysis.

Chong-Rui Li, Yu-Zhen Chen, Bin Li

|Mar 19, 2025
PYCR1 Promotes Esophageal Squamous Cell Carcinoma by Interacting With EGFR to Affecting the PI3K/Akt/mTOR Signaling Pathway.

Yu-Qi Meng, Hai-Ming Feng, Bin Li

Pageof 2

Frequent Collaborators

1 joint publications

Qiyao Yu

1 joint publications

Junfeng Liu